Quantification of [ C]ABP688 binding in human brain using cerebellum as reference region: biological interpretation and limitations

Michele S Milella,Luciano Minuzzi,Chawki Benkelfat,Jean-Paul Soucy,Alexandre Kirlow,Esther Schirrmacher,Mark Angle,Jeroen AJ Verhaeghe,Gassan Massarweh,Andrew J Reader,Antonio Aliaga,Jose Eduardo Peixoto-Santos,Marie-Christine Guiot,Eliane Kobayashi,Pedro Rosa-Neto,Marco Leyton

DOI: https://doi.org/10.1101/2024.02.12.24302279

2024-02-13

Abstract:data from primates provide conflicting evidence about the cerebellum’s suitability as a reference region for quantifying type 5 metabotropic glutamate receptor (mGluR5) binding parameters with positron emission tomography (PET). To address this, we first measured mGluR5 density in postmortem human cerebellum using [ H]ABP688 autoradiography (n=5) and immunohistochemistry (n=6). Next, experiments were conducted in healthy volunteers (n=6) using a high-resolution PET scanner (HRRT) to compare [ C]ABP688 binding potential (BP ) values obtained with reference tissue methods and the two-tissue compartment model vs. metabolite-corrected arterial input function. The postmortem data showed that, relative to the hippocampus, the cerebellum had 26% less mGluR5 immunoreactivity and 94% fewer [ H]ABP688 binding sites. brain regional [ C]ABP688 BP values using the cerebellum as a reference region were highly correlated with BP values and distribution volumes derived by arterial input methods (R > 0.9). The absence of cerebellar allosteric binding sites might reflect the presence of distinct mGluR5 isoforms or conformational state. Together with our PET data, these results support the proposition that [ C]ABP688 BP using cerebellum as a reference region provides accurate quantification of mGluR5 allosteric binding .

Radiology and Imaging